DETECT: No Long-term Harm From Paclitaxel Devices in PAD
A suggestion of reduced mortality with paclitaxel devices compared with controls requires more study, says Sahil Parikh.
A suggestion of reduced mortality with paclitaxel devices compared with controls requires more study, says Sahil Parikh.
Beyond late-breaking clinical trials, the presentation of the European Society of Cardiology (ESC) Guidelines has become a highly anticipated event at the
Documents show officials were told blood plasma harvested from US convicts was contaminated with viruses
Background: Primary ventricular fibrillation (VF) and sustained ventricular tachycardia (VT) are potentially lethal complications in patients suffering from acute myocardial infarction (MI). In contrast with…
The government will require school policies to include that cellphones be stored away during instructional time, except if explicitly permitted by the teacher
The CASTLE-HTx trial demonstrated the benefit of atrial fibrillation (AF) ablation compared to medical therapy in decreasing mortality, need for left ventricular assist device (LVAD)…
Listen to “You’ll Never Walk Alone” here: https://lnk.to/YNWAstrLIKE if you shed a tear listening to this ultimate football anthem! “The video is fitting wit…
Some dog owners in the Tenderloin, San Francisco’s mecca for open-air drug markets, say…
Meta had its worst trading day in 18 months after warning of years of AI investment. Shares of Microsoft and Google parent Alphabet rallied.
This cohort study evaluates recent reversals in declines in cardiovascular mortality and whether they vary across sociodemographic categories.
This cohort study examines data from climbers at Mount Everest to explore the incidence of tachyarrhythmias and bradyarrhythmias in healthy individuals at high altitudes.